PharmSource Webinar
Mixed Signals:
Understanding the Outlook for R&D Spending Through 2015
Wednesday, February 19, 2014
1-2 pm Eastern Time
REGISTER NOW! Speakers:
- Jim Miller, President, PharmSource
- Saul Richmond, Ph.D., Director of Market Intelligence, PharmSource
The pharmaceutical R&D services market is sending conflicting signals: new clinical trial starts are down, IPOs are up and start-ups are having trouble raising funding. With such contradictory information, how can R&D service providers reasonably assess their prospects for the next 2-3 years?
PharmSource's upcoming webinar, Mixed Signals: Understanding the Outlook for R&D Spending Through 2015, will help CROs and CDMOs understand what to expect for their businesses over the coming 24 to 36 month timeframe.
This data-intensive event will provide an expert outlook for bio/pharma R&D based on extensive analysis of R&D spending and financial trends. Get in on important information from PharmSource's considerable knowledge of the industry. Attendees will gain valuable insights on what's driving R&D spending and whether those changes bode well for contract services providers.
If you want important expert insight into the likely demand for clinical and CMC development services over the next few years, this webinar is a must-attend event that will help inform your key business decisions in 2014 and beyond. Attendees will receive PharmSource's slide deck from the presentation, and have the publisher's permission to use the data with citation.
Register now for this FREE event for PharmSource subscribers.
Bring your team to the call to listen, learn and
get answers to these questions and more:
- What are the prospects for the two major groupings of bio/pharma companies: those that self-fund their R&D and those that are dependent on external financing (IPOs, venture capital, etc.).
- How much of the funds raised during IPOs and secondary offerings goes to R&D? Is the IPO boom really a big benefit for CROs and CDMOs?
- What is the outlook for new funding for early stage companies? Will the money continue to flow?
- What explains the decline in new clinical trial starts? Are trials getting smaller?
- What is the impact of acquisitions and licensing activity by the global bio/pharma companies? Are they shrinking the level of spending and the number of candidates in play?
- What's the outlook for Europe versus North America?
PharmSource Webinar Summary
Mixed Signals:
Understanding the Outlook for R&D Spending Through 2015
| |
DATE: Wednesday, February 19, 2014
TIME: 1 pm Eastern Time
DURATION: 1 hour
LOCATION: Your desk or conference room
PRICE: FREE to PharmSource subscribers. $295/site for non-subscribers.
Bring your entire team together to benefit from the
expert strategic insights that will be learned. |
TO REGISTER CLICK HERE OR CALL +1-703-383-4903
About the Speakers:
Jim Miller is the Founder and President of PharmSource, which brings together buyers and sellers of contract services related to the development of drugs, medical devices and diagnostics. PharmSource is the trusted provider of global market and business intelligence for CROs and CMOs around the world. He holds an MBA degree from the Stanford University Graduate School of Business, and is a preeminent expert in bio/pharmaceutical outsourcing, Jim also serves as an Editorial Advisory Board member and columnist for Advanstar Communication's Pharmaceutical Technology and BioPharm magazines. He is a member of the Board of Directors of the American Type Culture Collection (ATCC).
Saul Richmond is PharmSource's Director of Market Intelligence. He brings over 15 years of experience in market analysis, having worked in business intelligence roles at Evaluate Pharma, Cardinal Health (now Catalent) and Abbott Laboratories. Prior to that, he was a Post-doctoral fellow in Neuropharmacology at the Universities of Birmingham and Bristol. Saul holds an MSc in Neuroscience from the Institute of Psychiatry, King's College London, and a D.Phil in Neuropharmacology from the University of Oxford.
REGISTER NOW!
Instant removal with SafeUnsubscribe™
PharmSource | PO Box 8163 | Springfield | VA | 22151 | www.pharmsource.com
|
